Inhibitors of Aβ production: Solid-phase synthesis and SAR of α-hydroxycarbonyl derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 6, 2003, Pages 1203-1206

  Wallace, Owen B ^a,b   Smith, David W ^a   Deshpande, Milind S ^a   Polson, Craig ^a   Felsenstein, Kevin M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYL GROUP; ALPHA HYDROXY KETONE DERIVATIVE; ALPHA HYDROXYCARBONYL DERIVATIVE; AMYLOID BETA PROTEIN; CARBONYL DERIVATIVE; ESTER DERIVATIVE; HYDROXYL GROUP; KETONE DERIVATIVE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ESTER;

ALZHEIMER DISEASE; ARTICLE; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SYNTHESIS; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; SYNTHESIS;

AMYLOID BETA-PROTEIN; DRUG DESIGN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTERS; INDICATORS AND REAGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037463802     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)01058-2     Document Type: Article

References (30)

1. Selkoe D.J. J. Neuropathol. Exp. Neurol. 53:1994;438.
2. (a) For recent reviews, see: Wolfe M.S. J. Med. Chem. 44:2001;2039
3. (b) Olson R.E., Copeland R.A., Seiffert D. Curr. Opin. Drug Disc. Dev. 4:2001;390.
4. Selkoe D.J. Annu. Rev. Cell Biol. 10:1994;373.
5. Cordell B. Annu. Rev. Pharmacol. Toxicol. 34:1994;69.
6. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Science. 248:1990;1122.
7. Rishton G.M., Retz D.M., Tempest P.A., Novotny J., Kahn S., Treanor J.J.S., Lile J.D., Citron M. J. Med. Chem. 43:2000;2297.
8. Moore C.L., Leatherwood D.D., Diehl T.S., Selkoe D.J., Wolfe M.S. J. Med. Chem. 43:2000;3434.
9. Dovey H.F., John V., Anderson J.P., Chen L.Z., de Saint Andrieu P., Fang L.Y., Freedman S.B., Folmer B., Goldbach E., Holsztynska E.J., Hu K.L., Johnson-Wood K.L., Kennedy S.L., Kholodenko D., Knops J.E., Latimer L.H., Lee M., Liao Z., Lieberburg I.M., Motter R.N., Mutter L.C., Nietz J., Quinn K.P., Sacchi K.L., Seubert P.A., Shopp G.M., Thorsett E.D., Tung J.S., Wu J., Yang S., Yin C.T., Schenk D.B., May P.C., Altstiel L.D., Bender M.H., Boggs L.N., Britton T.C., Clemens J.C., Czilli D.L., Dieckman-McGinty D.K., Droste J.J., Fuson K.S., Gitter B.D., Hyslop P.A., Johnstone E.M., Li W.-Y., Little S.P., Mabry T.E., Miller F.D., Ni B., Nissen J.S., Porter W.J., Potts B.D., Reel J.K., Stephenson D., Su Y., Shipley L.A., Whitesitt C.A., Yin T., Audia J.E. J. Neurochem. 76:2001;173.
10. Shearman M.S., Beher D., Clarke E.E., Huw D.L., Harrison T., Hunt P., Nadin A., Smith A.L., Stevenson G., Castro J.L. Biochemistry. 39:2000;8698.
11. See, for example: Castro Pineira, J. L.; Smith, A. L.; Stevenso, G. I. PCT Int. App. WO 0166564, 2001.
12. Transfected H4 (human neuroglioma) cells stably expressing APP constructs were used to evaluate compounds. The Aβ produced was detected by an ELISA. See: Smith, D. W.; Munoz, B.; Srinirvasan, K.; Bergstrom, C. P.; Chaturvedula, P. V.; Deshpande, M. S.; Keavy, D. J.; Lau, W. Y.; Parker, M. F.; Sloan, C. P.; Wallace, O. B.; Wang, H. H. WO 0050391. See also: Seubert, P.; Vigo-Pelfrey, C.; Esch F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Nature 1992, 359, 325.
13. Transfected H4 (human neuroglioma) cells stably expressing APP constructs were used to evaluate compounds. The Aβ produced was detected by an ELISA. See: Smith, D. W.; Munoz, B.; Srinirvasan, K.; Bergstrom, C. P.; Chaturvedula, P. V.; Deshpande, M. S.; Keavy, D. J.; Lau, W. Y.; Parker, M. F.; Sloan, C. P.; Wallace, O. B.; Wang, H. H. WO 0050391. See also: Seubert, P.; Vigo-Pelfrey, C.; Esch F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Nature 1992, 359, 325.
14. Higaki J.N., Chakravarty S., Bryant C.M., Cowart L.R., Harden P., Scardina J.M., Mavunkel B., Luedtke G.R., Cordell B. J. Med. Chem. 42:1999;3889.
15. (a) Felsenstein, K.; Smith, D. W.; Poss, M. A.; Chaturvedula, P.; Sloan, C. P. US-05703129, 1997.
16. (b) Durkin J.T., Murthy S., Husten E.J., Trusko S.P., Savage M.J., Rotella D.P., Greenberg B.D., Siman R. J. Biol. Chem. 274:1999;20499
17. (c) See also ref 7.
18. (a) Matsuda F., Matsumoto T., Ohsaki M., Ito Y., Terashima S. Bull. Chem. Soc. Jpn. 65:1992;360
19. (b) Paquet A. Can. J. Chem. 60:1982;976.
20. (a) Plunkett M.J., Ellman J.A. J. Am. Chem. Soc. 117:1995;3306
21. (b) Plunkett M.J., Ellman J.A. J. Org. Chem. 60:1995;6006.
22. The 24 carboxylic acids used were: 1-phenyl-1-cyclopropanecarboxylic acid; 2,2-dichloro-1-methyl-cyclopropanecarboxylic acid; 2,4,5-trimethoxy-alpha-methylcinnamic acid; 2-oxo-6-pentyl-2H-pyran-3-carboxylic acid; 3-(3-methoxyphenyl)propionic acid; 3-(phenylsulfonyl)propionic acid; 3,4-(methylenedioxy)-phenylacetic acid; 3,5-bis(trifluoromethyl)phenylacetic acid; 3,5-difluorophenylacetic acid; 3-phenoxyphenyl-acetic acid; 4′-ethyl-4-biphenylcarboxylic acid; 4-isopropoxybenzoic acid; 4-methylpentanoic acid; 4-n-heptyloxybenzoic acid; 4-nitrobenzoic acid; 7-methoxy-coumarin-4-acetic acid; α-acetamidocinnamic acid; α-cyclopentylphenylacetic acid; benzoic acid; benzoylformic acid; mono-methyl cis-5-norbornene-endo-2,3-dicarboxylate; N,N-diethyl-3,6-difluorophthalamic acid; phenylacetic acid and trans-2,6-difluorocinnamic acid.
23. This chemistry was undertaken using an Advanced Chemtech 396 peptide synthesizer. The average yield was 43%, based on the initial resin loading.
24. During method development, compounds were characterised by NMR and LCMS. During library synthesis, compounds were analysed by LCMS before submission for biological testing.
25. Wallace O.B. Tetrahedron Lett. 38:1997;4939.
26. 1=(S)-i-Pr].
27. Garofalo A.W., Wone D.W.G., Phuc A., Audia J.E., Bales C.A., Dovey H.F., Dressen D.B., Folmer B., Goldbach E.G., Guinn A.C., Latimer L.H., Mabry T.E., Nissen J.S., Pleiss M.A., Sohn S., Thorsett E.D., Tung J.S., Wu J. Bioorg. Med. Chem. Lett. 12:2002;3051.
28. 50 >75 μM).
29. See, for example: Patel D.V., Rielly-Gauvin K., Ryono D.E., Free C.A., Smith S.A., Petrillo E.W. Jr. J. Med. Chem. 36:1993;2431.
30. See ref 2 and references therein.